Company overview
Basic information
Company name
AB terapijos, MB
Company code
305777365
Registered address
Klaipėdos r. sav., Dovilų sen., Grambaviškių k., Klevų 7-oji g. 7, LT-96152
Registration date
2021-05-26
Company age: 5 y. 4 mo.
Contact information
Edit data
Phone
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Other human health activities n.e.c.
Ownership form
Private without foreign capital
MB "AB terapijos"
Company code: 305777365
Address: Klaipėdos r. sav., Dovilų sen., Grambaviškių k., Klevų 7-oji g. 7, LT-96152
Download a detailed company report
Make confident decisions with all the information about AB terapijos, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
AB terapijos, MB (company code 305777365) is an operational private small partnership registered in 2021. It is classified as a micro-sized private non-financial company under private ownership, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. Governance is limited to a CEO. The company is based in Grambaviškiu village, Dovilu eldership, Klaipeda district municipality, Klaipeda County.
The company’s activity is coded as EVRK R.86.99.00, Other human health activities n.e.c. Financially, it increased revenue from €7.5K in 2023 to €13.5K in 2024 and €17.9K in 2025. Net profit improved from a small loss of €145 in 2023 to a profit of €1.9K in 2024, then remained positive at €70 in 2025. Profit margin was 0.4% in 2025 after 14.1% in 2024 and -1.9% in 2023. The balance sheet remained small, with total assets of €501 in 2025 and negative equity of €1.2K, while liabilities stood at €1.7K.
The company’s activity is coded as EVRK R.86.99.00, Other human health activities n.e.c. Financially, it increased revenue from €7.5K in 2023 to €13.5K in 2024 and €17.9K in 2025. Net profit improved from a small loss of €145 in 2023 to a profit of €1.9K in 2024, then remained positive at €70 in 2025. Profit margin was 0.4% in 2025 after 14.1% in 2024 and -1.9% in 2023. The balance sheet remained small, with total assets of €501 in 2025 and negative equity of €1.2K, while liabilities stood at €1.7K.